COMP <GO>
RSKD vs PG // PIOTROSKI F-SCORE QUALITY
Riskified Ltd. (Class A) (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: RSKD 4
— PG 6
■ METRIC PARITY
LAST: $8.99 (-0.55%) • MKT CAP: $1.22B
piotroski-score
7/9
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RSKD VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RSKD | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 51.70% | 51.20% | +0.50 | RSKD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.30% | 25.40% | -45.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.71% | 3.77% | -1.06 | PG | /fcf-yield <GO> |
| Operating Margin | -9.90% | 24.30% | -34.20 | PG | /operating-margins <GO> |
| Net Profit Margin | -8.00% | 19.00% | -27.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | 0.30% | +4.90 | RSKD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.12 | 5.59 | +0.53 | RSKD | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 60.3 | +1.50 | RSKD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.22B | $372.21B | -$370.99B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RSKD REV | PG REV | RSKD GROSS % | PG GROSS % | RSKD FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $344.6M | $84.28B | 51.7% | 51.2% | $33.1M | $14.04B |
| FY 2024 | $327.5M | $84.04B | 52.2% | 51.4% | $39.1M | $16.52B |
| FY 2023 | $297.6M | $82.01B | — | — | $7.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RSKD // BETA —
PG // BETA 0.87